WO2006055004A8 - Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer - Google Patents

Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer

Info

Publication number
WO2006055004A8
WO2006055004A8 PCT/US2004/039083 US2004039083W WO2006055004A8 WO 2006055004 A8 WO2006055004 A8 WO 2006055004A8 US 2004039083 W US2004039083 W US 2004039083W WO 2006055004 A8 WO2006055004 A8 WO 2006055004A8
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
useful
detection
treatment
nucleic acids
Prior art date
Application number
PCT/US2004/039083
Other languages
French (fr)
Other versions
WO2006055004A1 (en
Inventor
Arthur B Raitano
Aya Jakobovits
Pia M Challita-Eid
Steven B Kanner
Wangmao Ge
Juan J Perez-Villar
Robert Kendall Morrison
Original Assignee
Agensys Inc
Arthur B Raitano
Aya Jakobovits
Pia M Challita-Eid
Steven B Kanner
Wangmao Ge
Juan J Perez-Villar
Robert Kendall Morrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc, Arthur B Raitano, Aya Jakobovits, Pia M Challita-Eid, Steven B Kanner, Wangmao Ge, Juan J Perez-Villar, Robert Kendall Morrison filed Critical Agensys Inc
Priority to PCT/US2004/039083 priority Critical patent/WO2006055004A1/en
Priority to CA002588564A priority patent/CA2588564A1/en
Priority to EP04811746A priority patent/EP1824877A1/en
Publication of WO2006055004A1 publication Critical patent/WO2006055004A1/en
Publication of WO2006055004A8 publication Critical patent/WO2006055004A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A novel gene 158P3D2 and its encoded protein, and variants thereof, are described wherein 158P3D2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table 1. Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 158P3D2 can be used in active or passive immunization.
PCT/US2004/039083 2004-11-19 2004-11-19 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer WO2006055004A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/US2004/039083 WO2006055004A1 (en) 2004-11-19 2004-11-19 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
CA002588564A CA2588564A1 (en) 2004-11-19 2004-11-19 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
EP04811746A EP1824877A1 (en) 2004-11-19 2004-11-19 Nucleic acids corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/039083 WO2006055004A1 (en) 2004-11-19 2004-11-19 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer

Publications (2)

Publication Number Publication Date
WO2006055004A1 WO2006055004A1 (en) 2006-05-26
WO2006055004A8 true WO2006055004A8 (en) 2006-09-28

Family

ID=34959621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/039083 WO2006055004A1 (en) 2004-11-19 2004-11-19 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer

Country Status (3)

Country Link
EP (1) EP1824877A1 (en)
CA (1) CA2588564A1 (en)
WO (1) WO2006055004A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL284985B2 (en) 2015-02-18 2023-03-01 Enlivex Therapeutics R& D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
KR20170138534A (en) 2015-04-21 2017-12-15 엔리벡스 테라퓨틱스 리미티드 Therapeutically Administered Blood Apoptosis Cell Preparations and Uses Thereof
EP3416661A4 (en) 2016-02-18 2020-03-04 Enlivex Therapeutics Ltd. Combination immune therapy and cytokine control therapy for cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040003418A1 (en) * 2001-04-10 2004-01-01 Aya Jakobovits Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
CA2588564A1 (en) 2006-05-26
WO2006055004A1 (en) 2006-05-26
EP1824877A1 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
WO2004016734A3 (en) Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
WO2003022995A3 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
WO2003040340A3 (en) Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
WO2005118864A3 (en) Antibodies and related molecules that bind to psca proteins
EP2280030A3 (en) Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
WO2006105488A3 (en) Antibodies and related molecules that bind to 161p2f10b proteins
WO2009033094A3 (en) Antibodies and related molecules that bind to 24p4c12 proteins
IL171966A0 (en) Prostate stem cell antigen variants and pharmaceutical compositions based thereon
WO2004098515A3 (en) Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
WO2003050255A3 (en) Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
CY1113064T1 (en) NUCLEAR ACID AND CORRESPONDING PROTEIN WITH TITLE 184P1E2 USEFUL IN CANCER TREATMENT AND DETECTION
WO2004067716A3 (en) Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
WO2002072785A3 (en) Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
WO2002060953A3 (en) Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
WO2006055004A8 (en) Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
WO2002083928A3 (en) Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
WO2002092842A3 (en) Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
WO2004050828A3 (en) Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
WO2002095009A3 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
WO2004021977A3 (en) Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
WO2003085081A3 (en) Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
WO2002083068A8 (en) Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2588564

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004811746

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004811746

Country of ref document: EP